← Eichor
Study identifier: NCT06491992 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Chitosan Phonophresis on Cervical IN Smartphone Addicted Users

Condition: Cervical Pain  ·  Sponsor: October 6 University

PhaseNA
Planned participants30
Who can joinAll sexes, 16 Years to 18 Years
Healthy volunteersNo

About this study

A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.

This description comes directly from the study's public registry record.

Talk to the study team

Lama Saad El-Din ED Mahmoud  ·  01157592636  ·  lamaelsedawyy@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Lama S MahmoudAl Jīzah, Select State, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06491992